Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Zenith BIO CEO & Investor Conference 2017 Slides

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith BIO CEO & Investor Conference 2017 Slides

BearDownAZ

Feb 14, 2017 12:17PM

Re: Zenith BIO CEO & Investor Conference 2017 Slides

fouremm

Feb 14, 2017 04:36PM

Re: Zenith BIO CEO & Investor Conference 2017 Slides

BearDownAZ

Feb 14, 2017 06:39PM

Re: Zenith BIO CEO & Investor Conference 2017 Slides

SanFrancisco99

Feb 14, 2017 09:56PM

Re: Zenith BIO CEO & Investor Conference 2017 Slides

Nextblockbuster

Feb 15, 2017 08:23AM

Re: Zenith BIO CEO & Investor Conference 2017 Slides

tada

Feb 15, 2017 10:54AM

Re: Zenith BIO CEO & Investor Conference 2017 Slides

SanFrancisco99

Feb 15, 2017 02:10PM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith BIO CEO & Investor Conference 2017 Slides

posted on Feb 15, 2017 04:54PM

noretreat - then it should be easy for you to justify a $4 to $5 buyin price. Likely not what you wanted to hear!